tm
Seeing Is Believing
tm
Seeing Is Believing
RNAZ is currently covered by 1 analysts with an average price target of $10.55. This is a potential upside of $8.63 (449.48%) from yesterday's end of day stock price of $1.92.
Transcode Therapeutics's activity chart (see below) currently has 2 price targets and 11 ratings on display. The stock rating distribution of RNAZ is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 87.5% with an average time for these price targets to be met of 117 days.
Highest price target for RNAZ is $20, Lowest price target is $20, average price target is $20.
Most recent stock forecast was given by EMILY BODNAR from HC WAINWRIGHT on 06-Feb-2025. First documented stock forecast 07-Jun-2022.
Currently out of the existing stock ratings of RNAZ, 9 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$20
$18.02 (910.10%)
$3
26 days ago
(06-Feb-2025)
7/8 (87.5%)
$8.63 (75.90%)
117
What is RNAZ (Transcode Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on RNAZ (Transcode Therapeutics) with a proven track record?
Which analyst has the most public recommendations on RNAZ (Transcode Therapeutics)?
Which analyst is the currently most bullish on RNAZ (Transcode Therapeutics)?
